A renewed Strategic Plan

Uniting stakeholders to share knowledge, foster collaboration, enable solutions and to support the most critical issues, risks and challenges faced by the field

Increasing resources

Mobilizing new funding to support and grow the field of HIV vaccine research and development

Greater collaboration

Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts

News

Strengthening African leadership in the new EU-Africa global health research partnerships

The Enterprise welcomes the European Union (EU) commitment to increase health security in sub-Saharan Africa and Europe, building on the current partnership between the EU, its Member States and sub-Saharan countries. These partnerships are essential for facilitating research, developing and improving health technologies, which in turn contributes to reducing the burden of infectious diseases.

Upcoming event

Enterprise Workshop – Kigali 2019

Are you an African researcher or a clinician working on HIV vaccine research and development (R&D)? Are you interested in sharing your experience and the challenges you face in your daily work? Are you keen to develop practical solutions to support African researchers towards the development of a safe and effective HIV vaccine?

The Global HIV Vaccine Enterprise invites you to apply to attend an interactive half-day workshop in Kigali.

Timely topics

In 2012, the Enterprise launched Timely Topics in HIV Vaccines, a strategy series convening experts as rapidly as possible to analyze, address, and respond to unresolved and emerging priority issues in the field. Through an open call for proposals, the Enterprise is working to identify the most important strategic needs of the field and sponsoring think tanks, meetings, forums and other events to tackle these issues.

Newsletter

Sign up to receive the latest news of the Vaccine Enterprise and occasional information related to IAS activities related to vaccine research and development (Please read our Privacy Policy)

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.